Inherited variation in carcinogen-metabolizing enzymes and risk of colorectal polyps

Carcinogenesis

Volumn 28, Issue 2, 2007, Pages 328-341

  Goode, Ellen L ^a,b,c   Potter, John D ^a,b   Bamlet, William R ^c   Rider, David N ^c   Bigler, Jeannette ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARYLAMINE ACETYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE 1; ARYLAMINE ACETYLTRANSFERASE 2; CIGARETTE SMOKE; CYTOCHROME P450 1A1; HYDROLASE; MICROSOMAL EPOXIDE HYDROLASE; NONSTEROID ANTIINFLAMMATORY AGENT; SULFOTRANSFERASE; SULFOTRANSFERASE 1A1; SULFOTRANSFERASE 1A2; UNCLASSIFIED DRUG;

ADENOMATOUS POLYP; ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CASE CONTROL STUDY; CAUCASIAN; CIGARETTE SMOKING; COLON POLYP; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAT; PHENOTYPE; POLYP; PRIORITY JOURNAL; RECTUM POLYP; SAMPLE SIZE;

ADULT; AGED; CARCINOGENS; CASE-CONTROL STUDIES; COLONIC POLYPS; ENZYMES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; RISK FACTORS; VARIATION (GENETICS);

EID: 33847281000     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl135     Document Type: Article

References (91)

1. Ahmed,F.E. (2004) Effect of diet, life style, and other environmental/ chemopreventive factors on colorectal cancer development, and assessment of the risks. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev., 22, 91-147.
2. Kuper,H., Boffetta,P. and Adami,H.O. (2002) Tobacco use and cancer causation: Association by tumour type. J. Intern. Med., 252, 206-224.
3. Potter,J.D. (1999) Colorectal cancer molecules and populations. J. Natl Cancer Inst., 91, 916-932.
4. Boffetta,P., Jourenkova,N. and Gustavsson,P. (1997) Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control, 8, 444-472.
5. Kakiuchi,H., Watanabe,M., Ushijima,T., Toyota,M., Imai,K., Weisburger,J.H., Sugimura,T. and Nagao,M. (1995) Specific 5′-GGGA- 3′->5′-GGA-3′ mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine. Proc. Natl Acad. Sci. USA, 92, 910-914.
6. Slattery,M.L., Curtin,K., Anderson,K. et al. (2000) Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J. Natl Cancer Inst., 92, 1831-1836.
7. Giovannucci,E. (2001) An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev., 10, 725-731.
8. Sandhu,M.S., White,I.R. and McPherson,K. (2001) Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: A meta-analytical approach. Cancer Epidemiol. Biomarkers Prev., 10, 439-446.
9. Norat,T., Lukanova,A., Ferrari,P. and Riboli,E. (2002) Meat consumption and colorectal cancer risk: Dose-response meta-analysis of epidemiological studies. Int. J. Cancer, 98, 241-256.
10. World Cancer Research Fund (1997) Food, Nutrition and the Prevention of Cancer: A Global Perspective. American Institute for Cancer Research, Washington, DC.
11. Sinha,R., Kulldorff,M., Gunter,M.J., Strickland,P. and Rothman,N. (2005) Dietary benzo(a)pyrene intake and risk of colorectal adenoma. Cancer Epidemiol. Biomarkers Prev., 14, 2030-2034.
12. Lewin,M.H., Bailey,N., Bandaletova,T., Bowman,R., Cross,A.J., Pollock,J., Shuker,D.E. and Bingham,S.A. (2006) Red meat enhances the colonic formation of the DNA adduct 06-carboxymethyl guanine: implications for colorectal cancer risk. Cancer Res., 66, 1859-1865.
13. Kampman,E., Slattery,M.L., Bigler,J., Leppert,M., Samowitz,W., Caan,B.J. and Potter,J.D. (1999) Meat consumption, genetic susceptibility, and colon cancer risk: A United States multicenter case-control study. Cancer Epidemiol. Biomarkers Prev., 8, 15-24.
14. Xue,W. and Warshawsky,D. (2005) Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: A review. Toxicol. Appl. Pharmacol., 206, 73-93.
15. Hein,D.W. (2002) Molecular genetics and function of NAT1 and NAT2: Role in aromatic amine metabolism and carcinogenesis. Mutat. Res., 506-507, 65-77.
16. Glatt,H., Engelke,C.E., Pabel,U., Teubner,W., Jones,A.L., Coughtrie,M.W., Andrae,U., Falany,C.N. and Meinl,W. (2000) Sulfotransferases: Genetics and role in toxicology. Toxicol. Lett., 112-113, 341-348.
17. Adjei,A.A. and Weinshilboum,R.M. (2002) Catecholestrogen sulfation: possible role in carcinogenesis. Biochem. Biophys. Res. Commun., 292, 402-408.
18. Windmill,K.F., McKinnon,R.A., Zhu,X., Gaedigk,A., Grant,D.M. and McManus,M.E. (1997) The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: Functional and localization studies. Mutat. Res., 376, 153-160.
19. Shimada,T., Yun,C.H., Yamazaki,H., Gautier,J.C., Beaune,P.H. and Guengerich,F.P. (1992) Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol. Pharmacol., 41, 856-864.
20. Shimada,T. and Fujii-Kuriyama,Y. (2004) Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci., 95, 1-6.
21. Kawajiri,K. (1999) CYP1A1. IARC Sci. Publ., 148, 159-172.
22. Omiecinski,C.J., Hassett,C. and Hosagrahara,V. (2000) Epoxide hydrolase - polymorphism and role in toxicology. Toxicol. Lett., 112-113, 365-370.
23. Cascorbi,I., Drakoulis,N., Brockmoller,J., Maurer,A., Sperling,K. and Roots,I. (1995) Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: Correlation with phenotypic activity. Am. J. Hum. Genet., 57, 581-592.
24. Coughtrie,M.W.H. (2002) Sulfation through the looking glass - recent advances in sulfotransferase research for the curious. Pharmacogenomics J., 2, 297-308.
25. Zhu,X., Veronese,M.E., Iocco,P. and McManus,M.E. (1996) cDNA cloning and expression of a new form of human aryl sulfotransferase. Int. J. Biochem. Cell Biol., 28, 565-571.
26. Raftogianis,R.B., Wood,T.C. and Weinshilboum,R.M. (1999) Human phenol sulfotransferases SULT1A2 and SULT1A1: Genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochem Pharmacol., 58, 605-616.
27. Nowell,S., Green,B., Tang,Y.M., Wiese,R. and Kadlubar,F.F. (2005) Examination of human tissue cytosols for expression of sulfotransferase iIsoform 1A2 (SULT1A2) using a SULT1A2-specific antibody. Mol. Pharmacol., 67, 394-399.
28. Dooley,T.P., Haldeman-Cahill,R., Joiner,J. and Wilborn,T.W. (2000) Expression profiling of human sulfotransferase and sulfatase gene superfamilies in epithelial tissues and cultured cells. Biochem. Biophys. Res. Commun., 277, 236-245.
29. Kawajiri,K., Nakachi,K., Imai,K., Watanabe,J. and Hayashi,S. (1993) The CYP1A1 gene and cancer susceptibility. Crit. Rev. Oncol. Hematol., 14, 77-87.
30. Spurr,N.K., Gough,A.C., Stevenson,K. and Wolf,C.R. (1987) MspI-polymorphism detected with a cDNa probe for the P-450 I family on chromosome 15. Nucleic Acids Res., 15, 5901.
31. Cascorbi,I., Brockmoller,J. and Roots,I. (1996) A C4887A polymorphism in exon 7 of human CYP1A1: Population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res., 56, 4965-4969.
32. 1-450 cDNA probe. Cytogenet. Cell Genet., 46, 574-575.
33. Hassett,C., Lin,J., Carty,C.L., Laurenzana,E.M. and Omiecinski,C.J. (1997) Human hepatic microsomal epoxide hydrolase: Comparative analysis of polymorphic expression. Arch. Biochem. Biophys., 337, 275-283.
34. Hassett,C., Aicher,L., Sidhu,J.S. and Omiecinski,C.J. (1994) Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet., 3, 421-428.
35. Sabbagh,A. and Darlu,P. (2005) Inferring haplotypes at the NAT2 locus: the computational approach. BMC Genet., 6, 30.
36. Patin,E., Barreiro,L.B., Sabeti,P.C. et al. (2006) Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes. Am. J. Hum. Genet., 78, 423-436.
37. Morimoto,L.M., Newcomb,P.A., Ulrich,C.M., Bostick,R.M., Lais,C.J. and Potter,J.D. (2002) Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol. Biomarkers Prev., 11, 1012-1018.
38. Potter,J.D., Bigler,J., Fosdick,L., Bostick,R.M., Kampman,E., Chen,C., Louis,T.A. and Grambsch,P. (1999) Colorectal adenomatous and hyperplastic polyps: Smoking and N-acetyltransferase 2 polymorphisms. Cancer Epidemiol. Biomarkers Prev., 8, 69-75.
39. Ulrich,C.M., Bigler,J., Whitton,J.A., Bostick,R., Fosdick,L. and Potter,J.D. (2001) Epoxide hydrolase Tyr113His polymorphism 'is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol. Biomarkers Prev., 10, 875-882.
40. Potter,J.D., Bostick,R.M., Grandits,G.A., Fosdick,L., Elmer,P., Wood,J., Grambsch,P. and Louis,T.A. (1996) Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: The Minnesota Cancer Prevention Research Unit Case-Control Study. Cancer Epidemiol. Biomarkers Prev., 5, 779-784.
41. O'Brien,M.J., Winawer,S.J., Zauber,A.G. et al. (1990) The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology, 98, 371-379.
42. Willett,W.C., Sampson,L., Stampfer,M.J., Rosner,B., Bain,C., Witschi,J., Hennekens,C.H. and Speizer,F.E. (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am. J. Epidemiol., 122, 51-65.
43. Bigler,J., Chen,C. and Potter,J.D. (1997) Determination of human NAT2 acetylator genotype by oligonucleotide ligation assay. Biotechniques, 22, 682-684, 686, 688 passim.
44. Abecasis,G.R. and Cookson,W.O. (2000) GOLD - graphical overview of linkage disequilibrium. Bioinformatics, 16, 182-183.
45. Excoffier,L. and Slatkin,M. (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol., 12, 921-927.
46. Devlin,B. and Risch,N. (1995) A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics, 29, 311-322.
47. Jarvik,G.P., Hatsukami,T.S., Carlson,C. et al. (2003) Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease. Arterioscler. Thromb. Vasc. Biol., 23, 1465-1471.
48. Carlson,C.S., Eberle,M.A., Rieder,M.J., Yi,Q., Kruglyak,L. and Nickerson,D.A. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet., 74, 106-120.
49. Li,S.S., Khalid,N., Carlson,C. and Zhao,L.P. (2003) Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms. Biostatistics, 4, 513-522.
50. Zhao,L.P., Li,S.S. and Khalid,N. (2003) A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies. Am. J. Hum. Genet., 72, 1231-1250.
51. Schwarz,D., Kisselev,P., Cascorbi,I., Schunck,W.H. and Roots,I. (2001) Differential metabolism of benzo(a)pyrene and benzo(a)pyrene-7,8-dihydrodiol by human CYP1A1 variants. Carcinogenesis, 22, 453-459.
52. Lin,H.J., Probst-Hensch,N.M., Hughes,N.C. et al. (1998) Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas. Pharmacogenetics, 8, 269-281.
53. Tiemersma,E.W., Bunschoten,A., Kok,F.J., Glatt,H., de Boer,S.Y. and Kampman,E. (2004) Effect of SULT1A1 and NAT2 genetic polymorphism on the association between cigarette smoking and colorectal adenomas. Int. J. Cancer, 108, 97-103.
54. Kiss,I., Nemeth,A., Bogner,B., Pajkos,G., Orsos,Z., Sandor,J., Csejtey,A., Faluhelyi,Z., Rodler,I. and Ember,I. (2004) Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer. Anticancer Res., 24, 3965-3970.
55. Landi,S., Gemignani,F., Moreno,V., Gioia-Patricola,L., Chabrier,A., Guino,E., Navarro,M., de Oca,J., Capella,G. and Canzian,F. (2005) A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet. Genomics, 15, 535-546.
56. Lilla,C., Verla-Tebit,E., Risch,A., Jager,B., Hoffmeister,M., Brenner,H. and Chang-Claude,J. (2006) Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol. Biomarkers Prev., 15, 99-107.
57. Crabtree,M.D., Fletcher,C., Churchman,M., Hodgson,S.V., Neale,K., Phillips,R.K. and Tomlinson,I.P. (2004) Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases. Gut, 53, 271-276.
58. Lang,N.P., Chu,D.Z., Hunter,C.F., Kendall,D.C., Flammang,T.J. and Kadlubar,F.F. (1986) Role of aromatic amine acetyltransferase in human colorectal cancer. Arch. Surg., 121, 1259-1261.
59. Ilett,K.F., David,B.M., Detchon,P., Castleden,W.M. and Kwa,R. (1987) Acetylation phenotype in colorectal carcinoma. Cancer Res., 47, 1466-1469.
60. Sachse,C., Smith,G., Wilkie,M.J., Barrett,J.H., Waxman,R., Sullivan,F., Forman,D., Bishop,D.T. and Wolf,C.R. (2002) A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis, 23, 1839-1849.
61. Barrett,J.H., Smith,G., Waxman,R., Gooderham,N., Lightfoot,T., Garner,R.C., Augustsson,K., Wolf,C.R., Bishop,D.T. and Forman,D. (2003) Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. Carcinogenesis, 24, 275-282.
62. Ye,Z. and Parry,J.M. (2002) Meta-analysis of 20 case-control studies on N-acetyltransferase 2 acetylation status and colorectal cancer risk. Med. Sci. Monit., 8, CR558-CR565.
63. Hirvonen,A. (1999) Polymorphic NATs and cancer predisposition. IARC Sci. Publ., 148, 251-270.
64. Vineis,P. (2002) The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology, 181-182, 457-462.
65. Slattery,M.L., Potter,J.D., Samowitz,W., Bigler,J., Caan,B. and Leppert,M. (1998) NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev., 7, 1079-1084.
66. Chen,K., Jiang,Q.T. and He,H.Q. (2005) Relationship between metabolic enzyme polymorphism and colorectal cancer. World J. Gastroenterol., 11, 331-335.
67. Welfare,M.R., Cooper,J., Bassendine,M.F. and Daly,A.K. (1997) Relationship between acetylator status, smoking, diet and colorectal cancer risk in the north-east of England. Carcinogenesis, 18, 1351-1354.
68. Roberts-Thomson,I.C., Ryan,P., Khoo,K.K., Hart,W.J., McMichael,A.J. and Butler,R.N. (1996) Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet, 347, 1372-1374.
69. Probst-Hensch,N.M., Haile,R.W., Li,D.S., Sakamoto,G.T., Louie,A.D., Lin,B.K., Frankl,H.D., Lee,E.R. and Lin,H.J. (1996) Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas. Carcinogenesis, 17, 2125-2129.
70. Tiemersma,E.W., Voskuil,D.W., Bunschoten,A., Hogendoorn,E.A., Witteman,B.J.M., Nagengast,F.M., Glatt,H, Kok,F.J. and Kampman,E. (2004) Risk of colorectal adenomas in relation to meat consumption, meat preparation, and genetic susceptibility in a Dutch population. Cancer Causes Control, 15, 225-236.
71. Bamber,D.E., Fryer,A.A., Strange,R.C., Elder,J.B., Deakin,M., Rajagopal,R., Fawole,A., Gilissen,R.A., Campbell,F.C. and Coughtrie,M.W. (2001) Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer. Pharmacogenetics, 11, 679-685.
72. Wong,C.F., Liyou,N., LeggettB., Young,J., Johnson,A. and McManus,M.E. (2002) Association of the SULT1A1 R213H polymorphism with colorectal cancer. Clin. Exp. Pharmacol. Physiol., 29, 754-758.
73. Peng,C.T., Chen,J.C., Yeh,K.T., Wang,Y.F., Hou,M.F., Lee,T.P., Shih,M.C., Chang,J.Y. and Chang,J.G. (2003) The relationship among the polymorphisms of SULT1A1, 1A2 and different types of cancers in Taiwanese. Int. J. Mol. Med., 11, 85-89.
74. Nowell,S., Coles,B., Sinha,R., MacLeod,S., Luke Ratnasinghe,D., Stotts,C., Kadlubar,F.F., Ambrosone,C.B. and Lang,N.P. (2002) Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: Contribution of metabolic variation to risk. Mutat. Res., 506-507, 175-185.
75. Moreno,V., Glatt,H., Guino,E., Fisher,E., Meinl,W., Navarro,M., Badosa,J.M. and Boeing,H. (2005) Polymorphisms in sulfotransferases SULT1A1 and SULT1A2 are not related to colorectal cancer. Int. J. Cancer, 113, 683-686.
76. Kiss,I., Sandor,J., Pajkos,G., Bogner,B., Hegedus,G. and Ember,I. (2000) Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes. Anticancer Res., 20, 519-522.
77. Ishibe,N., Stampfer,M., Hunter,D.J., Hennekens,C. and Kelsey,K.T. (2000) A prospective study of cytochrome P450 1A1 polymorphisms and colorectal cancer risk in men. Cancer Epidemiol. Biomarkers Prev., 9, 855-856.
78. Slattery,M.L., Samowitz,W., Ma,K., Murtaugh,M., Sweeney,C., Levin,T.R. and Neuhausen,S. (2004) CYP1A1, cigarette smoking, and colon and rectal cancer. Am. J. Epidemiol., 160, 842-852.
79. Murtaugh,M., Sweeney,C., Ma,K.N., Caan,B.J. and Slattery,M.L. (2005) The CYP1A1 genotype may alter the association of meat consumption patterns and preparation with the risk of colorectal cancer in men and women. J. Nutr., 135, 179-186.
80. Hou,L., Chatterjee,N., Huang,W.Y. et al. (2005) CYP1A1 Va1462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Carcinogenesis, 26, 1122-1128.
81. Huang,W.Y., Chatterjee,N., Chanock,S. et al. (2005) Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol. Biomarkers Prev., 14, 152-157.
82. Tranah,G.J., Giovannucci,E., Ma,J., Fuchs,C., Hankinson,S.E. and Hunter,D.J. (2004) Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study. Carcinogenesis, 25, 1211-1218.
83. Robien, K., Curtin,K., Ulrich,C.M., Bigler,J., Samowitz,W., Caan,B., Potter,J.D. and Slattery,M.L. (2005) Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk. Cancer Epidemiol. Biomarkers Prev., 14, 1350-1352.
84. van der Logt,E.M., Bergevoet,S.M., Roelofs,H.M., Te Morsche,R.H., Dijk,Y.V., Wobbes,T., Nagengast,F.M. and Peters,W.H. (2006) Role of epoxide hydrolase, NAD(P)H: quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer. Mutat. Res., 593, 39-49.
85. Turner,F., Smith,G., Sachse,C., Lightfoot,T., Gamer,R.C., Wolf,C.R., Forman,D., Bishop,D.T. and Barrett,J.H. (2004) Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer. Int. J. Cancer, 112, 259-264.
86. Schaid,D.J., Rowland,C.M., Tines,D.E., Jacobson,R.M. and Poland,G.A. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet., 70, 425-434.
87. Stram,D.O., Leigh Pearce,C., Bretsky,P., Freedman,M., Hirschhorn,J.N., Altshuler,D., Kolonel,L.N., Henderson,B.E. and Thomas,D.C. (2003) Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum. Hered., 55, 179-190.
88. Zhao,J.H., Curtis,D. and Sham,P.C. (2000) Model-free analysis and permutation tests for allelic associations. Hum. Hered., 50, 133-139.
89. Cortessis,V. and Thomas,D.C. (2004) Toxicokinetic genetics: An approach to gene-environment and gene-gene interactions in complex metabolic pathways. IARC Sci. Publ., 127-150.
90. Benjamini,Y. and Hochberg,Y. (1995) Controlling the false discovery rate: A practical and poweral approach to multiple testing. J. Royal Stat. Soc. Ser. B, 57, 289.
91. Williams,J.A. (2001) Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: Why molecular epidemiologists should think about enzyme expression. Carcinogenesis, 22, 209-214.